Genome Sequencing Unveils the Role of Copy Number Variants in Hearing Loss and Identifies Novel Deletions With Founder Effect in the DFNB1 Locus

IF 3.3 2区 医学 Q2 GENETICS & HEREDITY
Zibin Lin, Jiale Xiang, Xiangzhong Sun, Nana Song, Xiaozhou Liu, Qinming Cai, Jing Yang, Haodong Ye, Jiangfan Xu, Hongfu Zhang, Jiguang Peng, Yu Sun, Zhiyu Peng
{"title":"Genome Sequencing Unveils the Role of Copy Number Variants in Hearing Loss and Identifies Novel Deletions With Founder Effect in the DFNB1 Locus","authors":"Zibin Lin,&nbsp;Jiale Xiang,&nbsp;Xiangzhong Sun,&nbsp;Nana Song,&nbsp;Xiaozhou Liu,&nbsp;Qinming Cai,&nbsp;Jing Yang,&nbsp;Haodong Ye,&nbsp;Jiangfan Xu,&nbsp;Hongfu Zhang,&nbsp;Jiguang Peng,&nbsp;Yu Sun,&nbsp;Zhiyu Peng","doi":"10.1155/2024/9517114","DOIUrl":null,"url":null,"abstract":"<p>Sensorineural hearing loss is a prevalent disorder with significant genetic involvement, which is often challenging to diagnose due to genetic heterogeneity. Exome sequencing (ES) has been a standard diagnostic tool for sensorineural hearing loss, but its limitations in detecting copy number variants (CNVs) and intronic variants have prompted the exploration of genome sequencing (GS) for improved diagnostic yield. We conducted GS on 46 hearing loss families with previously negative ES results and an additional cohort of 36 patients with a monoallelic pathogenic variant in <i>GJB2</i> (the most common deafness gene). Additionally, the impact of a previously unrecognized novel 125-kb deletion in the DFNB1 locus on <i>GJB2</i> expression was assessed using quantitative polymerase chain reaction (qPCR), and haplotype analysis was performed to characterize the deletion. GS diagnosed eight cases (17%, 8/46) in the ES-negative cohort, primarily attributed to CNVs (6/8). Notably, a previously unrecognized 125 kb deletion in the DFNB1 region was identified, affecting <i>GJB2</i> expression and characterizing it as a founder effect in East Asian. In 47 patients with a monoallelic <i>GJB2</i> variant, 15% (95% CI, 7.4%–28%) were diagnosed with DFNB1 deletions. Analysis of the gnomAD database revealed the prevalence and ethnic diversity of DFNB1 deletions, with the novel 125 kb deletion emerging as a prominent pathogenic variant in East Asian, non-Finnish European, and admixed American populations. Our study highlights the utility of GS in diagnosing sensorineural hearing loss. The identification of DFNB1 deletions underscores their significant contribution to hearing loss etiology, advocating for their inclusion in routine diagnostic testing. We propose GS as a primary genetic testing approach for patients with hearing loss, offering comprehensive genomic analysis and the potential for improved diagnostic accuracy.</p>","PeriodicalId":13061,"journal":{"name":"Human Mutation","volume":"2024 1","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/2024/9517114","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Mutation","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/2024/9517114","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

Abstract

Sensorineural hearing loss is a prevalent disorder with significant genetic involvement, which is often challenging to diagnose due to genetic heterogeneity. Exome sequencing (ES) has been a standard diagnostic tool for sensorineural hearing loss, but its limitations in detecting copy number variants (CNVs) and intronic variants have prompted the exploration of genome sequencing (GS) for improved diagnostic yield. We conducted GS on 46 hearing loss families with previously negative ES results and an additional cohort of 36 patients with a monoallelic pathogenic variant in GJB2 (the most common deafness gene). Additionally, the impact of a previously unrecognized novel 125-kb deletion in the DFNB1 locus on GJB2 expression was assessed using quantitative polymerase chain reaction (qPCR), and haplotype analysis was performed to characterize the deletion. GS diagnosed eight cases (17%, 8/46) in the ES-negative cohort, primarily attributed to CNVs (6/8). Notably, a previously unrecognized 125 kb deletion in the DFNB1 region was identified, affecting GJB2 expression and characterizing it as a founder effect in East Asian. In 47 patients with a monoallelic GJB2 variant, 15% (95% CI, 7.4%–28%) were diagnosed with DFNB1 deletions. Analysis of the gnomAD database revealed the prevalence and ethnic diversity of DFNB1 deletions, with the novel 125 kb deletion emerging as a prominent pathogenic variant in East Asian, non-Finnish European, and admixed American populations. Our study highlights the utility of GS in diagnosing sensorineural hearing loss. The identification of DFNB1 deletions underscores their significant contribution to hearing loss etiology, advocating for their inclusion in routine diagnostic testing. We propose GS as a primary genetic testing approach for patients with hearing loss, offering comprehensive genomic analysis and the potential for improved diagnostic accuracy.

Abstract Image

基因组测序揭示了拷贝数变异在听力损失中的作用,并在 DFNB1 基因座中发现了具有创始人效应的新缺失基因
感音神经性听力损失是一种普遍存在的疾病,与遗传有很大关系,但由于遗传异质性,诊断起来往往很困难。外显子组测序(ES)一直是感音神经性听力损失的标准诊断工具,但其在检测拷贝数变异(CNV)和内含子变异方面的局限性促使人们探索基因组测序(GS)以提高诊断率。我们对 46 个以前 ES 结果为阴性的听力损失家庭以及另外 36 个 GJB2(最常见的耳聋基因)单倍致病变体患者进行了基因组测序。此外,还使用定量聚合酶链式反应(qPCR)评估了 DFNB1 基因座中一个之前未被发现的新型 125-kb 缺失对 GJB2 表达的影响,并进行了单倍型分析以确定该缺失的特征。在 ES 阴性队列中,GS 诊断出 8 个病例(17%,8/46),主要归因于 CNV(6/8)。值得注意的是,在 DFNB1 区域发现了一个之前未被发现的 125 kb 缺失,影响了 GJB2 的表达,并将其定性为东亚人的创始效应。在47名单倍GJB2变异患者中,15%(95% CI,7.4%-28%)被诊断为DFNB1缺失。对gnomAD数据库的分析显示了DFNB1缺失的流行率和种族多样性,新型125 kb缺失在东亚、非芬兰裔欧洲人和混血美国人中成为一个突出的致病变异。我们的研究强调了 GS 在诊断感音神经性听力损失中的作用。DFNB1 基因缺失的鉴定强调了其对听力损失病因学的重要贡献,主张将其纳入常规诊断检测。我们建议将 GS 作为听力损失患者的主要基因检测方法,提供全面的基因组分析,并有可能提高诊断的准确性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Human Mutation
Human Mutation 医学-遗传学
CiteScore
8.40
自引率
5.10%
发文量
190
审稿时长
2 months
期刊介绍: Human Mutation is a peer-reviewed journal that offers publication of original Research Articles, Methods, Mutation Updates, Reviews, Database Articles, Rapid Communications, and Letters on broad aspects of mutation research in humans. Reports of novel DNA variations and their phenotypic consequences, reports of SNPs demonstrated as valuable for genomic analysis, descriptions of new molecular detection methods, and novel approaches to clinical diagnosis are welcomed. Novel reports of gene organization at the genomic level, reported in the context of mutation investigation, may be considered. The journal provides a unique forum for the exchange of ideas, methods, and applications of interest to molecular, human, and medical geneticists in academic, industrial, and clinical research settings worldwide.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信